samedan logo
 
 
 
spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising

Helga Schweissguth


Editorial

Victoria Parker

 

 

Connect with us on Twitter: follow @EBRmagazine
   

   


Click here to view the digital version of EBR

 

 


 


Click here to view the digital version of EBR BIO-Europe Supplement

 

 

 

ebr
 
 
Featured in this issue
BIO-Europe 2021 Supplement
Innovative Technology Revolutionises Vaccine Development

BioCopy

With vaccine development under the microscope, BioCopy discusses its new molecular copier technology, which offers effective and, above all, fast protection against upcoming pandemics and rapidly changing virus strains

Richter-Helm – The CDMO to Match Your Needs

Richter-Helm

One step ahead – biopharmaceutical production capacity enlargement
  BIO-Europe 2021 Supplement
The Potential of Pluripotent Stem Cells for ‘Off-the-Shelf’ Cell Therapy

Alessandra De Riva and Eirini Koutsouraki at Mogrify

Human pluripotent stem cells are characterised by their undifferentiated status, infinite self-renewal capacity, and ability to differentiate into any cell type in the body. These characteristics make them an appealing source for therapeutic applications, from regenerative therapy to immuno-oncology

spacer


Published quarterly in
January, April,
July, and October


 

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
News and Press Releases

Nemera breaks ground in Brazil through Milfra acquisition

With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development and production of both vaginal and rectal applicators, as well as oral dosers for the pharmaceutical industry.
More info >>

 
White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement